Drug Profile
Cancer vaccine - Protein Sciences
Alternative Names: CEA vaccine - Protein SciencesLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Protein Sciences Corporation
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Breast cancer
Most Recent Events
- 28 Aug 2017 Protein Sciences Corporation has been acquired by Sanofi
- 01 Feb 2017 The vaccine is available for licensing (http://www.proteinsciences.com/BEVS.htm#Lic)
- 28 Jan 2003 The vaccine is still available for licensing (http://www.proteinsciences.com)